MD Anderson research shows modern chemotherapies are tied to a small but significant increased risk of secondary MDS and AML in older breast cancer patients. These findings may help oncologists understand their patients’ risks and better inform discussions with them.
Childhood Leukemia Treatment Options: Chemotherapy, Stem Cell
Risk Factors for Leukemia
Blinatumomab Effective for Children with Relapsed Leukemia - NCI
Adult Acute Lymphoblastic Leukemia Treatment (PDQ®) - PDQ Cancer
Understanding Leukemia Relapse
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) - NCI
Lack of Vitamin D may Increase Chemo-Induced Neuropathy Risk in
Blood Cancers Overview - History, Advancements and Challenges
Leukemia in Elderly Adults